TerrAscend closes Aunt Mary's deal, expanding the case for TerrAscend stock
Published on 10/18/2026 at 13:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSRetail expansion and quarterly progress
- TerrAscend completed the USD 9 million Aunt Mary's transaction on October 16, 2026.
- Second-quarter revenue reached USD 67.10 million, up 3.30 percent year over year.
- TerrAscend expects to report its next results on November 5, 2026.
TerrAscend completed its USD 9 million Aunt Mary's transaction on October 16, 2026, adding a fifth New Jersey retail location and expanding its footprint to 21 dispensaries across five U.S. states and Canada. The deal gives TerrAscend stock a fresh operating milestone as the cannabis company works to grow revenue and cash flow.
The transaction was covered by MMJ Daily, which reported that Aunt Mary's generates more than USD 10 million in annualized revenue. TerrAscend agreed in June 2026 to pay USD 3 million through a five-year convertible debenture and USD 6 million in cash upon exercise of an option to purchase 35 percent of the dispensary.
What does the acquisition mean?
The immediate value is retail density rather than a large revenue contribution. Aunt Mary's becomes TerrAscend's fifth New Jersey location, and the company said the business would be accretive to EBITDA and free cash flow. Upon exercise of the option and other conditions, TerrAscend can fully consolidate Aunt Mary's in its financial statements, according to MMJ Daily.
Margins improved in the second quarter
TerrAscend's second-quarter 2026 revenue increased 3.30 percent year over year to USD 67.10 million, while first-half revenue from continuing operations rose 2.60 percent to USD 132.70 million. Gross margin reached 54.00 percent, up 290 basis points from the prior year, and adjusted EBITDA margin was 26.30 percent, up 170 basis points, according to Nasdaq.
Chronology: TerrAscend agreed to the USD 9 million Aunt Mary's transaction in June 2026; it reported USD 67.10 million of second-quarter revenue on August 6, 2026; and it closed the transaction on October 16, 2026.
When are the next results?
TradingView lists November 5, 2026 as TerrAscend's next earnings date. That report will show whether the new retail location and the company's margin gains are translating into sustained growth.
TSND stays tied to execution
TerrAscend's second-quarter operating cash flow was USD 7.40 million and free cash flow was USD 5.70 million, giving the expansion a financial backdrop beyond store count. The counterweight is leverage: total debt, net, stood at USD 197.30 million at June 30, 2026, while competition and pricing pressure remained key variables in management's outlook.
Canadian listing remains the market reference
TerrAscend was last at CAD 0.67 on the TSX on October 16, 2026 at 3:59 p.m. ET. The stock's 52-week range was CAD 0.53 to CAD 2.00, placing the latest quote below the midpoint of that range. The further course of trading is shown by the continuously updated real-time quote of TerrAscend stock.
TerrAscend stock facts
- Company: TerrAscend Corp.
- ISIN: CA88105E1088
- Ticker: TSND
- Primary exchange: TSX
- Last TSX price: CAD 0.67 as of October 16, 2026, 3:59 p.m. ET
- Market capitalization: CAD 207.1 million as of October 16, 2026
- 52-week range: CAD 0.53-CAD 2.00 as of October 16, 2026
- Sector / Industry: Healthcare / Drug Manufacturers - Specialty and Generic
- Next earnings date: November 5, 2026
Market context: Market report S&P/TSX Composite.
